CStone Pharmaceuticals Deal to Advance Clinical Development of DDR Asset
CStone Pharmaceuticals announced a deal to advance clinical development of an asset targeting the DDR pathway.
CStone Pharmaceuticals announced a deal to advance clinical development of an asset targeting the DDR pathway.